{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:07:03Z","timestamp":1789704423355,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06772-9","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:41:17Z","timestamp":1789702877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of urodynamics in overactive bladder: a critical in-depth analysis of the FUTURE study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-4925","authenticated-orcid":false,"given":"Claire","family":"Hentzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Serati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tufan","family":"Tarcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskinder","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Kirschner-Hermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"De Nunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Finazzi-Agro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"6772_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s13063-021-05661-3","volume":"22","author":"M Abdel-Fattah","year":"2021","unstructured":"Abdel-Fattah M, Chapple C, Guerrero K et al (2021) Invasive Urodynamic Investigations in the Management of Women With Refractory Overactive Bladder Symptoms (FUTURE) in the UK: A Multicentre, Superiority, Parallel, Open-Label, Randomised Controlled Trial. Trials 22:745","journal-title":"Trials"},{"key":"6772_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(24)01886-5","volume":"405","author":"M Abdel-Fattah","year":"2025","unstructured":"Abdel-Fattah M, Chapple C, Cooper D et al (2025) Invasive Urodynamic Investigations in the Management of Women With Refractory Overactive Bladder Symptoms (FUTURE) in the UK: A Multicentre, Superiority, Parallel, Open\u2010Label, Randomised Controlled Trial. Lancet 405:10484: 1057\u20131068","journal-title":"Lancet"},{"key":"6772_CR3","doi-asserted-by":"crossref","unstructured":"Tarcan T, Finazzi-Agro E, Serati M. The FUTURE Study in Refractory OAB: A Step Forward or a Step Back? Neurourol Urodyn 2025;;44(5):975\u2013976.","DOI":"10.1002\/nau.70072"},{"issue":"5","key":"6772_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2025.05.016","volume":"88","author":"M Serati","year":"2025","unstructured":"Serati M, Tarcan T, Peyronnet B et al (2025) Words of Wisdom re: FUTURE Study. Eur Urol 88(5):530","journal-title":"Eur Urol"},{"issue":"10517","key":"6772_CR5","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/S0140-6736(25)01291-7","volume":"406","author":"M Tutolo","year":"2025","unstructured":"Tutolo M, Ammirati E, Montorsi F (2025) Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study. Lancet 406(10517):2320\u20132321","journal-title":"Lancet"},{"issue":"10517","key":"6772_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/S0140-6736(25)01289-9","volume":"406","author":"M Serati","year":"2025","unstructured":"Serati M, Tarcan T, Peyronnet B et al (2025) Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study. Lancet 406(10517):2321\u20132322","journal-title":"Lancet"},{"issue":"10517","key":"6772_CR7","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/S0140-6736(25)01290-5","volume":"406","author":"TM Kessler","year":"2025","unstructured":"Kessler TM, Bachmann LM, Betschart C (2025) Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study. Lancet 406(10517):2322","journal-title":"Lancet"},{"issue":"5","key":"6772_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bju.70189","volume":"137","author":"E Solomon","year":"2026","unstructured":"Solomon E, Peyronnet B, Sahai A et al (2026) The \u2018FUTURE\u2019 of urodynamics in the management of female overactive bladder symptoms. BJU Int 137(5):783\u2013785","journal-title":"BJU Int"},{"issue":"5","key":"6772_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.23736\/S2724-6051.25.06532-2","volume":"77","author":"A Braga","year":"2025","unstructured":"Braga A, Espuna-Pons M, Serati M, on behalf of EUGA (2025) Future study: when a trial could be confusing. Minerva Urol Nephrol 77(5):736\u2013737","journal-title":"Minerva Urol Nephrol"},{"key":"6772_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejogrb.2019.10.046","volume":"244","author":"M Serati","year":"2020","unstructured":"Serati M, Tarcan T, Finazzi-Agro E et al (2020) The bladder is an unreliable witness: The case for urodynamic investigations in female stress urinary incontinence. Eur J Obs Gynecol Reprod Biol 244:35\u201337","journal-title":"Eur J Obs Gynecol Reprod Biol"},{"key":"6772_CR11","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1113595","volume":"366","author":"CW Nager","year":"2012","unstructured":"Nager CW, Brubaker L, Litman HJ et al (2012) A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 366:1987\u20131997","journal-title":"N Engl J Med"},{"key":"6772_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/AOG.0b013e31828c68e3","volume":"121","author":"SA van Leijsen","year":"2013","unstructured":"van Leijsen SA, Kluivers KB, Mol BW et al (2013) Value of urodynamics before stress urinary incontinence surgery: a randomized con-trolled trial. Obstet Gynecol 121:999\u20131008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"6772_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.eururo.2020.06.004","volume":"78","author":"MJ Drake","year":"2020","unstructured":"Drake MJ, Lewis AL, Young GJ et al (2020) Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals. Eur Urol 78(5):701\u2013710","journal-title":"Eur Urol"},{"key":"6772_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/nau.25273","volume":"42","author":"T Tarcan","year":"2023","unstructured":"Tarcan T, Finazzi-Agro E, Kessler TM et al (2023) How should prospective research be designed to legitimately assess the value of urodynamic studies in female urinary incontinence? Neurourol Urodyn 42:1639\u20131646","journal-title":"Neurourol Urodyn"},{"key":"6772_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.euf.2018.07.031","volume":"6","author":"E Finazzi-Agr\u00f2","year":"2020","unstructured":"Finazzi-Agr\u00f2 E, Gammie A, Kessler TM et al (2020) Urodynamics Useless in Female Stress Urinary Incontinence? Time for Some Sense\u2014A European Expert Consensus. Eur Urol Focus 6:137\u2013145","journal-title":"Eur Urol Focus"},{"key":"6772_CR16","unstructured":"OCEBM Levels of Evidence Oxford Centre for Evidence-Based Medicine. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence"},{"issue":"3","key":"6772_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.euf.2019.09.020","volume":"6","author":"CR Chapple","year":"2020","unstructured":"Chapple CR, Mironska E, Wagg A et al (2020) Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex. Eur Urol Focus 6(3):522\u2013530","journal-title":"Eur Urol Focus"},{"key":"6772_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/nau.21021","volume":"30","author":"E Rovner","year":"2011","unstructured":"Rovner E, Kennelly M, Schulte-Baukloh H et al (2011) Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxin A in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn 30:556\u2013562","journal-title":"Neurourol Urodyn"},{"key":"6772_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","volume":"64","author":"C Chapple","year":"2013","unstructured":"Chapple C, Sievert K-D, MacDiarmid S et al (2013) Onabotulinumtoxin A 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol 64:249\u2013256","journal-title":"Eur Urol"},{"issue":"1","key":"6772_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/luts.12196","volume":"11","author":"E Malde","year":"2019","unstructured":"Malde E, Spilotros M et al (2019) Female bladder outlet obstruction: Common symptoms masking an uncommon cause. Low Urin Tract Symptoms 11(1):72\u201377","journal-title":"Low Urin Tract Symptoms"},{"issue":"4","key":"6772_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/nau.20503","volume":"27","author":"S Al-Hayek","year":"2008","unstructured":"Al-Hayek S, Belal M, Abrams P (2008) Does the patient\u2019s position influence the detection of detrusor overactivity? Neurourol Urodyn 27(4):279\u2013286","journal-title":"Neurourol Urodyn"},{"key":"6772_CR22","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C et al (2019) A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 75:988\u20131000","journal-title":"Eur Urol"},{"key":"6772_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ et al (2024) The AUA\/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. J Urol 212:11\u201320","journal-title":"J Urol"},{"issue":"4","key":"6772_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00192-017-3414-4","volume":"29","author":"TS Verghese","year":"2018","unstructured":"Verghese TS, Middleton LJ, Daniels JP et al (2018) The impact of urodynamics on treatment and outcomes in women with an overactive bladder: a longitudinal prospective follow-up study. Int Urogynecol J 29(4):513\u2013519","journal-title":"Int Urogynecol J"},{"issue":"6","key":"6772_CR25","first-page":"823","volume":"73","author":"M Serati","year":"2021","unstructured":"Serati M, Cantaluppi S, Coluccia AC et al (2021) Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder? Minerva Urol Nephrol 73(6):823\u2013830","journal-title":"Minerva Urol Nephrol"},{"key":"6772_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/toxins17100479","volume":"17","author":"MP Roman","year":"2025","unstructured":"Roman MP, Ciortea R, Doumouchtsis SK et al (2025) Comparison of Different Treatment Outcomes for Refractory Overactive Bladder: A Systematic Review and Meta-Analysis. Toxins 17:479","journal-title":"Toxins"},{"issue":"5","key":"6772_CR27","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/nau.24932","volume":"41","author":"M Serati","year":"2022","unstructured":"Serati M, Braga A, Rosier PFWM et al (2022) Acceptability and perceived value of urodynamics from the patient perspective: A narrative review. Neurourol Urodyn 41(5):1065\u20131073","journal-title":"Neurourol Urodyn"},{"key":"6772_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1046\/j.1365-2648.2000.01627.x","volume":"32","author":"C Shaw","year":"2000","unstructured":"Shaw C, Williams K, Assassa PR et al (2000) Patient satisfaction with urodynamics: a qualitative study. J Adv Nurs 32:1356\u20131363","journal-title":"J Adv Nurs"},{"key":"6772_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00192-017-3386-4","volume":"29","author":"A Rezvan","year":"2018","unstructured":"Rezvan A, Amaya S, Betson L et al (2018) Randomized controlled trial of the effect of environment on patient embarrassment and anxiety with urodynamics. Int Urogynecol J 29:291\u2013296","journal-title":"Int Urogynecol J"},{"key":"6772_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/nau.20810","volume":"29","author":"A Majumdar","year":"2010","unstructured":"Majumdar A, Latthe P, Toozs-Hobson P Urodynamics prior to treatment as an intervention: A pilot study. Neurourol Urodyn (2010) ; 29:522\u2013526","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"6772_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.23736\/S0393-2249.20.03685-1","volume":"72","author":"M Serati","year":"2020","unstructured":"Serati M, Iacovelli V, Cantaluppi s et al (2020) Impact of urodynamic evaluation on the treatment of women with idiopathic overactive bladder: a systematic review. Minerva Urol Nefrol 72(4):420\u2013426","journal-title":"Minerva Urol Nefrol"},{"key":"6772_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/bju.16703","volume":"136","author":"H Bell-Gorrod","year":"2025","unstructured":"Bell-Gorrod H, Thokala P, Breeman S et al (2025) Long-term cost-effectiveness of invasive urodynamic studies for overactive bladder in women. BJU Int 136:82\u201394","journal-title":"BJU Int"},{"issue":"6","key":"6772_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.eururo.2025.06.017","volume":"88","author":"CR Chapple","year":"2025","unstructured":"Chapple CR, Wagg A, Harding C et al (2025) From Clinical Trials to Routine Practice: Are Urodynamics Still Useful? Eur Urol 88(6):537\u2013539","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06772-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06772-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06772-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:41:20Z","timestamp":1789702880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06772-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6772"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06772-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C Hentzen is consultant to Bbraun, Convatec and Coloplast and received a speaker honorarium from Ipsen, Wellspect, Convatec. B Peyronnet is consultant to Intuitive, Boston Scientific, Abbvie, Medtronic, Ipsen, Pierre Fabre, Ibsa, Coloplast, Convatec. M Serati is consultant to Laborie and Pierre Fabre. T Tarcan is consultant to DEVA, Viatris, Laborie and received a speaker honorarium from Recordati. E Solomon is consultant to Laborie, and has received research support from Medtronics. R Kirschner Hermanns is the founder and CEO of MEC-ABC GmbH, Germany President of the German Charity Association \u2018F\u00f6rderverein f\u00fcr Kontinenzforschung und Kontinenzaufkl\u00e4rung e. V.\u2018. E Finazzi Agro is consultant to Laborie, Pierre Fabre and received a speaker honorarium from Recordati, Convatec. C de Nunzio and T Kessler have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"674"}}